Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sulfanitran is a synthetic sulfonamide antibiotic used primarily in the poultry industry as a feed additive to control coccidiosis, an intestinal disease caused by *Eimeria* species such as *E. tenella, E. necatrix*, and *E. acervulina*. It is included in veterinary products under the brand names Novastat, Polystat, and Unistat. As a member of the sulfonamide class, its mechanism of action involves competitive inhibition of bacterial dihydropteroate synthase—an enzyme essential for folic acid synthesis—thereby inhibiting DNA and RNA synthesis in susceptible organisms. This results in bacteriostatic activity rather than bactericidal effects. Sulfanitran is not approved for human use; its application is limited to veterinary medicine.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sulfanitran.